Literature DB >> 23928160

Near-infrared fluorescence glucose sensing based on glucose/galactose-binding protein coupled to 651-Blue Oxazine.

Faaizah Khan1, John C Pickup.   

Abstract

Near-infrared (NIR) fluorescent dyes that are environmentally sensitive or solvatochromic are useful tools for protein labelling in in vivo biosensor applications such as glucose monitoring in diabetes since their spectral properties are mostly independent of tissue autofluorescence and light scattering, and they offer potential for non-invasive analyte sensing. We showed that the fluorophore 651-Blue Oxazine is polarity-sensitive, with a marked reduction in NIR fluorescence on increasing solvent polarity. Mutants of glucose/galactose-binding protein (GBP) used as the glucose receptor were site-specifically and covalently labelled with Blue Oxazine using click chemistry. Mutants H152C/A213R and H152C/A213R/L238S showed fluorescence increases of 15% and 21% on addition of saturating glucose concentrations and binding constants of 6 and 25mM respectively. Fluorescence responses to glucose were preserved when GBP-Blue Oxazine was immobilised to agarose beads, and the beads were excited by NIR light through a mouse skin preparation studied in vitro. We conclude GBP-Blue Oxazine shows proof-of-concept as a non-invasive continuous glucose sensing system.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blue Oxazine; CGM; DMF; Diabetes; FRET; GBP; Glucose sensor; Glucose/galactose-binding protein; NIR; Near infrared fluorescence; Ni–NTA; PBS; continuous glucose monitoring; dimethylformamide; fluorescence resonance energy transfer; glucose/galactose-binding protein; near-infrared; nickel nitrolotriacetic acid; phosphate-buffered saline

Mesh:

Substances:

Year:  2013        PMID: 23928160     DOI: 10.1016/j.bbrc.2013.07.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  A Monte Carlo-quantum mechanics study of a solvatochromic π* probe.

Authors:  Moisés Domínguez; Marcos Caroli Rezende
Journal:  J Mol Model       Date:  2016-08-24       Impact factor: 1.810

2.  Tryptophan residue of the D-galactose/D-glucose-binding protein from E. Coli localized in its active center does not contribute to the change in intrinsic fluorescence upon glucose binding.

Authors:  Olga V Stepanenko; Alexander V Fonin; Olesya V Stepanenko; Maria Staiano; Sabato D'Auria; Irina M Kuznetsova; Konstantin K Turoverov
Journal:  J Fluoresc       Date:  2014-12-11       Impact factor: 2.217

3.  Osmolyte-Like Stabilizing Effects of Low GdnHCl Concentrations on d-Glucose/d-Galactose-Binding Protein.

Authors:  Alexander V Fonin; Alexandra D Golikova; Irina A Zvereva; Sabato D'Auria; Maria Staiano; Vladimir N Uversky; Irina M Kuznetsova; Konstantin K Turoverov
Journal:  Int J Mol Sci       Date:  2017-09-19       Impact factor: 5.923

Review 4.  Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field.

Authors:  Xiaomin Yi; Fuli Wang; Weijun Qin; Xiaojian Yang; Jianlin Yuan
Journal:  Int J Nanomedicine       Date:  2014-03-05

5.  A novel fluorescent sensor protein for detecting changes in airway surface liquid glucose concentration.

Authors:  Nordine Helassa; James P Garnett; Matthew Farrant; Faaizah Khan; John C Pickup; Klaus M Hahn; Christopher J MacNevin; Robert Tarran; Deborah L Baines
Journal:  Biochem J       Date:  2014-12-01       Impact factor: 3.857

6.  Direct electrical quantification of glucose and asparagine from bodily fluids using nanopores.

Authors:  Nicole Stéphanie Galenkamp; Misha Soskine; Jos Hermans; Carsten Wloka; Giovanni Maglia
Journal:  Nat Commun       Date:  2018-10-05       Impact factor: 14.919

7.  A modified fluorescent sensor for reporting glucose concentration in the airway lumen.

Authors:  Jade Bearham; Nina Krutrök; Botilda Lindberg; Maximillian Woodall; Annika Astrand; John D Taylor; Matthew Biggart; Stanislavs Vasiljevs; Robert Tarran; Deborah L Baines
Journal:  PLoS One       Date:  2021-07-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.